Therapeutics Company Announces Partnership With To Accelerate Novel Alzheimer's Treatment

Combating Alzheimer's Disease, Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-centric biopharmaceutical company, has recently announced a partnership with LTS Therapy Systems, LLC ("LTS"). This collaboration aims to expedite the development and production of the HT-ALZ oral film prototype, a promising therapeutic solution for Alzheimer's Disease based on its compelling preclinical results disclosed earlier this year. $Hoth Therapeutics(HOTH.US)$